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Abstract
Background
Multiple occasions of device-measured physical activity have not been previously examined
in relation to metabolic traits. We described associations of total activity, moderate-to-vigor-
ous physical activity (MVPA), and sedentary time from three accelerometry measures taken
across adolescence with detailed traits related to systemic metabolism.
Methods and findings
There were 1,826 male and female participants recruited at birth in 1991–1992 via mothers
into the Avon Longitudinal Study of Parents and Children offspring cohort who attended clin-
ics in 2003–2005, 2005–2006, and 2006–2008 who were included in1 analysis. Waist-
worn uniaxial accelerometers measured total activity (counts/min), MVPA (min/d), and sed-
entary time (min/d) over3 d at mean age 12y, 14y, and 15y. Current activity (at age 15y),
mean activity across occasions, interaction by previous activity, and change in activity were
examined in relation to systolic and diastolic blood pressure, insulin, C-reactive protein, and
230 traits from targeted metabolomics (nuclear magnetic resonance spectroscopy), includ-
ing lipoprotein cholesterol and triglycerides, amino and fatty acids, glycoprotein acetyls,
and others, at age 15y. Mean current total activity was 477.5 counts/min (SD = 164.0) while
mean MVPA and sedentary time durations were 23.6 min/d (SD = 17.9) and 522.1 min/d
(SD = 66.0), respectively. Mean body mass index at age 15y was 21.4 kg/m2 (SD = 3.5).
Correlations between first and last activity measurement occasions were low (e.g., r = 0.40
for counts/min). Current activity was most strongly associated with cholesterol and triglycer-
ides in high-density lipoprotein (HDL) and very low-density lipoprotein (VLDL) particles
(e.g., −0.002 mmol/l or −0.18 SD units; 95% CI −0.24–−0.11 for triglycerides in chylomicrons
and extremely large very low-density lipoprotein [XL VLDL]) and with glycoprotein acetyls
(−0.02 mmol/l or −0.16 SD units; 95% CI −0.22–−0.10), among others. Associations were
similar for mean activity across 3 occasions. Attenuations were modest with adjustment for
fat mass index based on dual-energy X-ray absorptiometry (DXA). In mutually adjusted
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models, higher MVPA and sedentary time were oppositely associated with cholesterol and
triglycerides in VLDL and HDL particles (MVPA more strongly with glycoprotein acetyls and
sedentary time more strongly with amino acids). Associations appeared less consistent for
sedentary time than for MVPA based on longer-term measures and were weak for change
in all activity types from age 12y–15y. Evidence was also weak for interaction between
activity types at age 15y and previous activity measures in relation to most traits (minimum
P = 0.003; median P = 0.26 for counts/min) with interaction coefficients mostly positive.
Study limitations include modest sample sizes and relatively short durations of accelerome-
try measurement on each occasion (3–7 d) and of time lengths between first and last accel-
erometry occasions (<4 years), which can obscure patterns from chance variation and limit
description of activity trajectories. Activity was also recorded using uniaxial accelerometers
which predated more sensitive triaxial devices.
Conclusions
Our results support associations of physical activity with metabolic traits that are small in
magnitude and more robust for higher MVPA than lower sedentary time. Activity fluctuates
over time, but associations of current activity with most metabolic traits do not differ by previ-
ous activity. This suggests that the metabolic effects of physical activity, if causal, depend
on most recent engagement.
Author summary
Why was this study done?
• Much of what is known about the benefits of physical activity for population health
comes from studies using one-off measures of activity. Activity fluctuates over time,
however, and such measures may not capture longer-term exposure or describe its true
health effects.
• Previous studies examining associations of physical activity and sedentary time as
recorded by an accelerometer device with metabolism have not only lacked repeated
activity measures but have also been limited in the scope and detail of metabolic traits
described. Deeper phenotyping could reveal specific pathways through which physical
activity may protect against type 2 diabetes and heart disease.
What did the researchers do and find?
• We examined relations of physical activity with metabolism by integrating data from
three repeat measures of accelerometry taken on separate occasions across adolescence
with data from targeted metabolomics. This allowed us to compare associations of cur-
rent activity, longer-term activity, and change in activity with detailed traits related to
systemic metabolism. This also allowed us to see whether associations of current activity
with metabolic traits depend on previous activity (e.g., whether effects are cumulative or
acute).
Device-measured activity and metabolic traits
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• We found higher total activity to associate widely across metabolic traits including
higher cholesterol in high-density lipoprotein (HDL) particles, lower cholesterol and tri-
glycerides in very low-density lipoprotein (VLDL) particles, and lower inflammatory
glycoprotein acetyls, among others. Associations were small in magnitude and more
robust for higher moderate-to-vigorous activity than lower sedentary time. We also
found that activity levels fluctuate over time but that associations of current activity with
most metabolic traits do not differ by previous activity.
What do these findings mean?
• Beneficial effects of higher physical activity on metabolic health, if causal and not just
reflective of unmeasured aspects of body size, may be driven more by time spent
intensely active than by less time spent sitting down. These effects are probably small
and short lived, meaning that physical activity would need to be engaged in regularly to
prevent disease.
Introduction
Cardiometabolic diseases contribute the most to non-violent death rates worldwide [1]. Those
chiefly responsible for this contribution are type 2 diabetes, coronary heart disease (CHD),
and stroke [1], all of which have origins in dysfunctional metabolism [2]. Decades of observa-
tional studies have established dose–response associations of higher duration and intensity of
physical activity with reduced risk of cardiometabolic diseases and their precursors [3–5].
Physical activity is now commonly measured using accelerometry devices which track inten-
sity and duration of body movement—an advance over self-report methods, which are prone
to measurement error from imprecise and biased recall and can thereby mask the true magni-
tude of associations [6,7]. Accelerometer data are often collected over several days to estimate
mean activity level. Such measures, however, still only describe a single measurement occasion
in the lifespan of a cohort and may only provide a snapshot of longer-term activity.
The few studies that have repeat accelerometry data report considerable instability over
time [8–11], but repeat accelerometry has not been examined in relation to metabolic traits
beyond adiposity [8] and fatty liver [11]. It is therefore unclear how longer-term activity and
change in activity are associated with metabolic traits. This also has implications for under-
standing the dynamic nature of physical activity effects—whether they are acute or cumulative.
One-off accelerometry measures of sedentary time are also associated with metabolic traits
[12,13] and mortality risk [14], although repeated measures are also scarce. Importantly, there
are limited data on physical activity and sedentary time in relation to detailed metabolic traits
derived from novel metabolomics platforms. These could help clarify mechanisms underlying
potential activity benefits by revealing specific components of summary traits such as serum
cholesterol that track alongside activity. One recent study examined accelerometry at a single
time point in relation to metabolites from untargeted mass spectrometry [15,16], while one
examined repeated activity with self-report in relation to more clinically relevant metabolomic
traits from targeted nuclear magnetic resonance (NMR) [17].
The extent to which adiposity confounds associations of physical activity with metabolic
traits is also unclear [18]. Adverse effects of higher adiposity on metabolic trait levels are
Device-measured activity and metabolic traits
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002649 September 11, 2018 3 / 26
strongly supported by prospective observational [19], instrumental variable [20], and surgical
reversal [21] studies, while recent instrumental variable studies [22–24] also suggest that
higher adiposity reduces activity and lengthens sedentary time. Alternatively, physical activity
may help mediate effects of adiposity on metabolic functioning if activity is truly causal for
such traits.
This study integrated data from three repeat measures of accelerometry taken on separate
occasions across adolescence with data from targeted NMR metabolomics to better describe
associations of current and longer-term physical activity and sedentary time with detailed
traits related to systemic metabolism. Interaction by previous activity and change in activity
were also investigated in relation to these traits. Confounding by adiposity was examined in
each instance with adjustment for dual-energy X-ray absorptiometry (DXA)-assessed fat mass
index.
Methods
A prospective analysis plan written in March 2017 before analyses were conducted is included
as S1 Protocol. Analyses were not changed following peer review. This study is reported
according to the Strengthening the Reporting of Observational Studies in Epidemiology
(STROBE) guidelines (checklist included as S1 STROBE Checklist).
Study population
Data were drawn from offspring participants of the Avon Longitudinal Study of Parents and
Children (ALSPAC), a population-based birth cohort study in which 14,541 pregnant women
with an expected delivery date between 1 April 1991 and 31 December 1992 were recruited
from the former county of Avon in southwest England. Offspring who were alive at 1 year
(n = 13,988) have since been followed with multiple assessments [25], with an additional 713
children enrolled over the course of the study. Clinical data for present analyses were collected
in 2003–2005, 2005–2006, and 2006–2008. Ethical approval was obtained from the ALSPAC
Law and Ethics Committee and the Local Research Ethics Committees. Cohort details and
data descriptions are available at www.bristol.ac.uk/alspac/researchers/access.
Assessment of physical activity and sedentary time
Physical activity was assessed with a waist-worn uniaxial ActiGraph device (AM7164 2.2, Acti-
Graph LLC, Fort Walton Beach, FL, United States of America) on three occasions at approxi-
mate mean ages of 12y, 14y, and 15y. On each occasion, the device was worn during waking
hours for up to 7 d, during which participants recorded device wear time and timing of activi-
ties such as swimming or cycling. Nonwear periods were identified as 10 or more minutes of
consecutive zero counts and were deleted from each processing file [26]. A day of accelerome-
try was considered valid if at least 600 minutes of activity were recorded. Participants were
included if they had at least 3 valid days of accelerometry on occasions relevant to that analysis.
Data are recorded as counts that result from summing postfiltered accelerometer values (raw
data at 30 Hz) into epoch units. Count values vary based on raw acceleration frequency and
intensity and the filtering process by which counts are produced are specific to ActiGraph.
Total physical activity was expressed as the mean number of counts per minute (CPM) on
valid days. Duration of moderate-to-vigorous physical activity (MVPA) was expressed as the
mean number of daily minutes spent at or above 3,600 CPM on valid days. Duration of seden-
tary time was expressed as the mean number of daily minutes spent below 199 CPM on valid
days. Activity derivations are further described elsewhere [26,27]. The general term ‘activity’ is
used here to describe total movement intensity (based on counts/min), and terms ‘MVPA’ and
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‘sedentary time’ are used to describe the amount of time spent in the higher and lower end of
the movement intensity spectrum, respectively.
Assessment of metabolic traits
As part of a clinical assessment at approximately age 15y, systolic and diastolic blood pressure
(SBP and DBP, respectively) were examined twice in succession while seated with the arm
supported using an appropriately-sized cuff and a DINAMAP 9301 device. Mean values were
used to estimate resting levels. Fasting blood samples were drawn, from which circulating
insulin (mu/l) and C-reactive protein (mg/l) were quantified. Proton NMR spectroscopy was
performed as part of a targeted metabolomics platform [28] to quantify 230 metabolic traits
(150 concentrations plus 80 ratios) including the concentration and size of lipoproteins and
their cholesterol and triglyceride content, lipid and glycaemic precursors including fatty acids
and amino acids, inflammatory factors, and others.
Assessment of covariates
Basic demographic traits considered were sex, age (in months) at the time of physical activity
assessment, ethnicity (‘white’ versus ‘non-white’), and the highest level of education attained
by the participant’s mother as reported near the time of delivery (‘Certificate of Secondary
Education’; ‘vocational’; ‘O-level’; ‘A-level’; or ‘degree’ using English standards) as an indicator
of socioeconomic position at birth. Maternal education has shown similar association patterns
as paternal education and head of household occupational social class in ALSPAC with regards
to offspring general health as indicated by length at birth and growth through childhood [29].
At approximately age 15y, smoking behaviour was estimated via questionnaire and grouped as
‘never smoked’, ‘has smoked a whole cigarette but does not smoke weekly’, and ‘smokes at
least once per week’. Alcohol consumption was estimated via questionnaire at age 15y and
grouped as ‘never consumed’, ‘consumed once/twice or occasionally in the past’, ‘consumes
less than weekly’, and ‘consumes at least once per week’. These questionnaires were part of
repeat self-reported behaviour assessments starting from age 10y [25,30]. At age 12y, 14y, and
15y, participants underwent body scanning with DXA using a Lunar Prodigy narrow fan beam
densitometer, from which estimates of total body fat mass (in kg, excluding lean and bone
mass) were obtained. Scans were screened for anomalies, motion, and material artefacts and
were realigned when necessary as detailed elsewhere [31]. Height was measured while in light
clothing without shoes, recorded to the nearest 0.1 cm using a Harpenden stadiometer. Fat
mass index (FMI) was calculated by dividing total fat mass by the square of height (in meters).
Body mass index (BMI) was also calculated using weight (as kg/m2) for descriptive purposes.
Accelerometer wear time was based on the total number of minutes recorded on valid days.
The month in which the accelerometer was worn was also considered to account for seasonal
variation in activity.
Statistical approach
All activity and metabolic traits were converted into standardised (z-score) units for analyses
(mean = 0.0; SD = 1.0). Pearson correlation coefficients were examined between each activity
trait at age 12y (first recorded measure) and 15y (last recorded measure) (e.g., CPM at 12y
with CPM at 15y). This was used to estimate the relative stability of each activity trait over
time.
In the first set of analyses, associations of total activity (CPM), MVPA duration, and sed-
entary duration at age 15y were examined in relation to metabolic traits at age 15y using
separate linear regression models with robust standard errors to accommodate skewed
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outcome distributions in replace of log transformations. Models of CPM were adjusted for
covariates in two cumulative stages: 1) for age at the time of CPM assessment, sex, ethnicity,
maternal education, smoking, alcohol, and accelerometer wear time and wear month; and
2) for FMI at the time of CPM assessment to examine effect size attenuations. Models of
MVPA and sedentary time were adjusted for covariates in three cumulative stages: 1) for
age at the time of exposure assessment, sex, ethnicity, maternal education, and accelerome-
ter wear time and wear month; 2) for the alternative activity measure (MVPA or sedentary
time); and 3) for FMI at the time of MVPA or sedentary time assessment to examine effect
size attenuations.
In the second set of analyses, associations were examined between levels of each activity
trait calculated as the mean of three standardised measurement occasion values (at age 12y,
14y, and 15y) representing a current measure plus two historical measures in relation to meta-
bolic traits at age 15y using separate linear models. Covariate adjustments were arranged as
previous except that adjustments for MVPA or sedentary time, accelerometer wear time, and
FMI were all based on the mean of three measures (at age 12y, 14y, and 15y). Linear models
were also constructed to examine interaction terms of each activity measure at 15y with the
mean of its two historical measures (e.g., CPM at age 15y with mean of CPM at 14y and 12y)
in relation to metabolic traits at age 15y. P-values from these interaction terms and coefficient
directions were used as evidence of whether associations of current activity with metabolic
traits differ according to historical activity.
In the third set of analyses, associations of change in each activity trait from age 12y–15y
(calculated as standardised trait at 15y minus standardised trait at 12y) were examined in rela-
tion to metabolic traits at age 15y. Adjustment for age was based on age at 12y. Smoking and
alcohol measures were excluded as these did not precede initial exposure assessment. Adjust-
ment for MVPA/sedentary time, accelerometer wear time, and FMI were each based on
change values from age 12y–15y.
Supplementary analyses
To better examine directionality of associations of activity with metabolic traits, the most-
adjusted models above were further adjusted for metabolic trait values measured using the
same blood pressure and NMR assessment techniques at an available pre-baseline occasion,
at approximately age 8y. For example, total activity at 15y in relation to glycoprotein acetyls
at 15y was examined with adjustment for glycoprotein acetyls at 8y. Insulin and C-reactive
protein were excluded from this analysis as they were not measured at this 8y pre-baseline
occasion.
For comparison with metabolic trait outcomes, we additionally examined associations of
each activity exposure in relation to FMI at age 15y as an outcome (rather than a confounder).
Models were otherwise adjusted for the same set of covariates described previously and were
then examined with further adjustment for FMI measured using DXA at a pre-baseline occa-
sion, at approximately age 10y to better address directionality of associations.
All above analyses were performed on an unrestricted sample of participants with data for
each separate outcome allowing sample sizes to vary. Analyses were repeated on a complete-
case sample of participants who had data for all variables (each activity trait on all three occa-
sions, plus all covariates, plus all metabolic traits at age 15y) to examine the potential for incon-
sistent sample size from nonrandom missing data to bias results.
Seventeen principal components explained 95% of the variance in these highly correlated
metabolic traits in previous ALSPAC analyses [32], approximating the number of independent
tests for use in Bonferroni multiple testing corrections. Here, we focus on effect size and
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precision and interpret P values as continuous indicators of evidence strength [33,34]. Analy-
ses were conducted using Stata 15.1 (StataCorp, College Station, Texas, USA).
Results
Sample characteristics
There were 1,826 participants included in at least one analysis (i.e., had at least 3 valid days of
accelerometry data at age 15y, plus data on at least one metabolic trait at age 15y, plus data on
all step-one covariates). Selection of eligible participants is illustrated in Fig 1. Mean age was
15.4 (SD = 0.2) y and mean time between age 12y and 15y measurement occasions was 3.7
(SD = 0.3) y. A small majority of included participants was female (55.6%), while a minority
was of a nonwhite ethnicity (3.6%). Weekly smoking and weekly drinking were rare (4.9% and
15.3%, respectively). At age 15y, mean total physical activity was 477.5 (SD = 164.0) CPM,
mean MVPA duration was 23.6 (SD = 17.9) min/d, and mean sedentary time was 522.1
(SD = 66.0) min/d. Among participants with at least 3 valid days of accelerometry at age 15y,
72.2% had at least 5 valid days, while 22.0% had 7 valid days. Across ages 12y, 14y, and 15y,
total activity decreased, MVPA was relatively stable, and sedentary time increased. Other char-
acteristics are shown in Table 1.
Compared with included participants, excluded participants were slightly older, more likely
to be male and of a nonwhite ethnicity, more likely to have low maternal education, and more
likely to smoke and consume alcohol weekly at age 15y (all in S1 Table). FMI did not differ at
age 15y between included and excluded participants. Excluded participants had slightly more
adverse insulin and inflammatory profiles, and slightly higher total activity yet lower sedentary
time at age 12y, 14y, and 15y.
Correlations between repeated measures of physical activity and sedentary
time
Among 1,826 eligible participants, CPM measured at age 12y was low-to-moderately corre-
lated with CPM measured at age 15y (Pearson r = 0.40), likewise when separated by sex
Fig 1. Selection of participants from the ALSPAC offspring cohort eligible for 1 analysis. ALSPAC, Avon
Longitudinal Study of Parents and Children.
https://doi.org/10.1371/journal.pmed.1002649.g001
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(r = 0.34 for males, r = 0.36 for females). MVPA at age 12y was also low-to-moderately corre-
lated with its measure at age 15y (r = 0.39 among all participants; 0.30 versus 0.36 among
males and females, respectively). Sedentary time at age 12y was correlated with its measure at
age 15y at 0.32 among all participants; this was higher among males than females (0.38 versus
0.25). Correlations were slightly larger between the earlier two measures (age 12y and 14y) at
0.45 for CPM, 0.41 for MVPA, and 0.41 for sedentary time with a slighter sex disparity for
Table 1. Characteristics of eligible participants from the ALSPAC offspring cohort.
Participants included in 1 analysis (n = 1,826)
Demographics
Exact age (years) at 15y clinic—mean (SD) 15.4 (0.2)
Female—percentage (n) 55.6 (1,015)
Nonwhite ethnicity—percentage (n) 3.6 (66)
Low maternal education—percentage (n) 50.5 (922)
Smokes at least weekly at age 15y—percentage (n) 4.9 (89)
Consumes alcohol at least weekly at age 15y—percentage (n) 15.3 (280)
Fat mass index (kg/m2) at age 15y—mean (SD) 5.6 (3.3)
Body mass index (kg/m2) at age 15y—mean (SD) 21.4 (3.5)
Has obesity at age 15y—percentage (n) 4.2 (75)
Activity traits at age 12y
Total (counts/min)—mean (SD) 586.0 (168.3)
Duration of moderate-to-vigorous (min/d)—mean (SD) 21.7 (14.0)
Duration of sedentary (min/d)—mean (SD) 434.5 (64.7)
Activity traits at age 14y
Total (counts/min)—mean (SD) 528.1 (177.9)
Duration of moderate-to-vigorous (min/d)—mean (SD) 23.3 (16.2)
Duration of sedentary (min/d)—mean (SD) 489.4 (68.1)
Activity traits at age 15y
Total (counts/min)—mean (SD) 477.5 (164.0)
Duration of moderate-to-vigorous (min/d)—mean (SD) 23.6 (17.9)
Duration of sedentary (min/d)—mean (SD) 522.1 (66.0)
Summary metabolic traits at age 15y
SBP (mmHg)—mean (SD) 123.1 (10.4)
DBP (mmHg)—mean (SD) 67.5 (8.5)
Total cholesterol (mmol/l)—mean (SD) 3.6 (0.6)
LDL cholesterol (mmol/l)—mean (SD) 1.1 (0.3)
HDL cholesterol (mmol/l)—mean (SD) 1.4 (0.2)
Triglycerides (mmol/l)—mean (SD) 0.9 (0.3)
Insulin (mu/l)—median (range) 8.9 (1.2–39.6)
Glucose (mmol/l)—mean (SD) 4.3 (0.3)
Glycoprotein acetyls (mmol/l)—mean (SD) 1.2 (0.1)
C-reactive protein (mg/l)—median (range) 0.38 (0.1–72.6)
Participants described are those with data on accelerometry at age 15y, data on at least one metabolic trait at 15y, and
data on step-one covariates. ‘Low maternal education’ defined as highest level of education attained being Certificate
of Secondary Education, vocational, or O level (not A level or degree).
Based on a BMI threshold for obesity ( 28.56 kg/m2 for males and 29.19 kg/m2 for females) at mean age 15.4y
equivalent to 30.00 kg/m2 at age 18y [35].
Abbreviations: ALSPAC, Avon Longitudinal Study of Parents and Children; BMI, body mass index; DBP, diastolic
blood pressure; HDL, high-density lipoprotein; LDL, low-density lipoprotein; SBP, systolic blood pressure.
https://doi.org/10.1371/journal.pmed.1002649.t001
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sedentary time (0.42 for males, 0.38 for females). Magnitudes were similar for the latter two
measures (age 14y and 15y) at 0.43 for CPM, 0.45 for MVPA, and 0.38 for sedentary time with
a higher sex disparity for both MVPA (0.38 for males, 0.44 for females) and sedentary time
(0.42 for males, 0.32 for females). All coefficients were P< 0.001.
Current physical activity and sedentary time (at age 15y) in relation to
metabolic traits at age 15y
Total activity (per SD [164 CPM] higher) was associated with numerous metabolic traits at
age 15y (Figs 2 and 3; full results in S2 Table). Associations were weak with SBP and DBP but
stronger with very low-density lipoprotein (VLDL) particle concentrations and lipid fractions
(e.g., −1.19 × 10−11 mmol/l or −0.17 SD units; 95% CI = −0.24, −0.11; P = 1.78 × 10−7 for con-
centration of chylomicrons and extremely large very low-density lipoprotein [XL VLDL] parti-
cles). Associations were weaker with intermediate-density lipoprotein (IDL) and low-density
lipoprotein (LDL) but stronger with high-density lipoprotein (HDL) particles, particularly
large HDL. Higher total activity was associated with lower total VLDL cholesterol (−0.02
mmol/l or −0.13 SD units; 95% CI = −0.20, −0.07; P = 5.13 × 10−5) and higher total HDL
cholesterol (0.03 mmol/l or 0.13 SD units; 95% CI = 0.07, 0.20; P = 3.80 × 10−5) but was
Fig 2. Associations of total activity (CPM) with blood pressure, cholesterol, and triglycerides at age 15y in ALSPAC. Metabolic traits are in
standardised units. Current activity defined as measure at age 15y. Longer-term activity defined as mean of 3 measures (at age 12y, 14y, and 15y).
Change in activity defined as difference between measures at age 12y and 15y. Models are adjusted for age, sex, ethnicity, maternal education, device
wear time and wear month, smoking and alcohol (for current activity), and fat mass index (based on current, mean, or change values) across measures
at age 12y, 14y, and 15y. ALSPAC, Avon Longitudinal Study of Parents and Children; CPM, counts per minute.
https://doi.org/10.1371/journal.pmed.1002649.g002
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unassociated with total LDL cholesterol (−0.007 mmol/l or −0.02 SD units; 95% CI = −0.09,
0.04; P = 0.44). This pattern was observed for VLDL, HDL, and LDL particle diameter. Lower
overall triglyceride concentrations were observed with higher total activity, as well as triglycer-
ides within VLDL and HDL but not LDL particles. Strong associations were also observed
with apolipoprotein B, with apolipoprotein B to A1 ratio, with omega 6 to total and polyunsat-
urated to total fatty acid ratios, and with glycoprotein acetyls. Effect size attenuations across
traits were modest upon adjustment for FMI (e.g., from −0.16 to −0.11 SD units for glycopro-
tein acetyls).
Similar association patterns and effect sizes were observed across traits with current MVPA
(per SD [18 min/d] higher) as with total activity. The strongest associations were observed
with cholesterol and triglycerides in VLDL and HDL particles; with diameter of VLDL and
HDL particles; and with apolipoproteins and glycoprotein acetyls (S3 Table). Attenuations
were minimal with adjustment for sedentary time and modest with further adjustment for
FMI (e.g., from −0.15 to −0.16 to −0.11 SD units for glycoprotein acetyls). Sedentary time (per
SD [66 min/d] higher) showed comparatively weaker associations with most traits; these had
opposing directions of effect, particularly for cholesterol and triglycerides in VLDL and HDL
particles (full results in S4 Table). Associations were positive with DBP and with VLDL particle
Fig 3. Associations of total activity (CPM) with lipoprotein particle diameter, apolipoproteins, fatty acids, glycolysis factors, amino acids,
ketones, and inflammatory factors at age 15y in ALSPAC. Metabolic traits are in standardised units. Current activity defined as measure at age 15y.
Longer-term activity defined as mean of 3 measures (at age 12y, 14y, and 15y). Change in activity defined as difference between measures at age 12y
and 15y. Models are adjusted for age, sex, ethnicity, maternal education, device wear time and wear month, smoking and alcohol (for current activity),
and fat mass index (based on current, mean, or change values) across measures at age 12y, 14y, and 15y. ALSPAC, Avon Longitudinal Study of Parents
and Children; CPM, counts per minute.
https://doi.org/10.1371/journal.pmed.1002649.g003
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concentrations and fractions (e.g., 5.62 × 10−12 mmol/l or 0.08 SD units; 95% CI = 0.02, 0.15;
P = 0.01 for concentration of chylomicrons and XL VLDL); negative with HDL-related traits,
particularly small HDL; and nearly zero with IDL- and LDL-related traits. Stronger associa-
tions were observed with amino acids (e.g., alanine at 0.01 mmol/l or 0.12 SD units; 95%
CI = 0.05, 0.18; P = 7.32 × 10−4). With adjustment for MVPA, effect size attenuation was sub-
stantial across VLDL-related traits but slight to nil for DBP, small HDL traits, and alanine.
These effect sizes were not much attenuated with further adjustment for FMI. These results are
shown in Figs 4 and 5.
Fig 4. Mutually adjusted associations of current MVPA and sedentary time with blood pressure, cholesterol, and triglycerides at age 15y in
ALSPAC. Metabolic traits are in standardised units. Current MVPA/sedentary time defined as measure at age 15y. Models are adjusted for age, sex,
ethnicity, maternal education, device wear time and wear month, smoking, alcohol, alternative measure (MVPA or sedentary time), and fat mass index
at age 15y. ALSPAC, Avon Longitudinal Study of Parents and Children; MVPA, moderate-to-vigorous physical activity.
https://doi.org/10.1371/journal.pmed.1002649.g004
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Longer-term physical activity and sedentary time (mean across age 12y,
14y, and 15y) in relation to metabolic traits at age 15y
Based on 3 measures, total activity (per SD [132 CPM] higher) was similarly associated with
most metabolic traits at age 15y versus total activity based on a single measure at age 15y (Figs
2 and 3; full results in S5 Table). Effect sizes increased for several traits, particularly SBP (from
−0.05 to −0.13 SD units), HDL particle concentrations and fractions, total VLDL, LDL, and
HDL cholesterol, insulin (from −0.09 to −0.14 SD units), and inflammatory glycoprotein
acetyls (from −0.16 to −0.20 SD units). Attenuation of these upon adjustment for FMI based
on 3 measures was more substantial versus by FMI at age 15y only in previous analyses. For
Fig 5. Mutually adjusted associations of current MVPA and sedentary time with lipoprotein particle diameter, apolipoproteins, fatty acids,
glycolysis factors, amino acids, ketones, and inflammatory factors at age 15y in ALSPAC. Metabolic traits are in standardised units. Current
MVPA/sedentary time defined as measure at age 15y. Models are adjusted for age, sex, ethnicity, maternal education, device wear time and wear
month, smoking, alcohol, alternative measure (MVPA or sedentary time), and fat mass index at age 15y. ALSPAC, Avon Longitudinal Study of Parents
and Children; MVPA, moderate-to-vigorous physical activity.
https://doi.org/10.1371/journal.pmed.1002649.g005
Device-measured activity and metabolic traits
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002649 September 11, 2018 12 / 26
example, SBP attenuated from −0.13 to −0.08 SD units and glycoprotein acetyls from −0.20 to
−0.11 SD units.
MVPA (per SD [12 min/d] based on 3 measures) was also similarly associated with meta-
bolic traits versus MVPA based on a single measure (S6 Table). Effect sizes increased for sev-
eral traits including SBP (from −0.06 to −0.14 SD units), HDL-related traits, insulin (from
−0.08 to −0.14 SD units), and glycoprotein acetyls (from −0.15 to −0.21 SD units). Attenua-
tions were slight with adjustment for sedentary time based on 3 measures and modest with
adjustment for FMI based on 3 measures (e.g. from −0.21 to −0.15 SD units for glycoprotein
acetyls). Sedentary time (per SD [50 min/d] higher based on 3 measures) appeared more
strongly associated with most metabolic traits versus sedentary time based on a single measure
(S7 Table), with several effect sizes having increased, particularly for small HDL-related traits,
pyruvate (from 0.08 to 0.15 SD units), and alanine. Attenuations were slight to nil with adjust-
ment for MVPA and for FMI, each based on 3 measures (e.g., from −0.23 to −0.21 to −0.20 SD
units for total cholesterol in small HDL). The direction of effect size appeared to flip for choles-
terol and triglycerides in VLDL and LDL particles, while the direction of effect remained con-
sistently inverse with cholesterol and triglycerides in HDL particles, particularly medium and
small HDL. These are shown in Figs 6 and 7.
P values for an interaction term between total activity at age 15y and the mean of its two his-
torical measures (at ages 12y and 14y) in relation to metabolic traits at age 15y ranged from
P = 0.003 to P = 1.00 with a median P = 0.26 (S8 Table). Likewise, P values for an interaction
term between MVPA and the mean of its two historical measures in relation to metabolic traits
were high (ranging from P = 0.05 to P = 1.00; median P = 0.58). P values for an interaction
term between current and historical sedentary measures in relation to metabolic traits ranged
from P = 3.95 × 10−4 to P = 1.00 (median P = 0.36). The magnitude of interaction term P values
for total activity, MVPA, and sedentary time were also inconsistent in relation to each meta-
bolic trait and interaction term coefficients were largely in a positive direction. Together, this
provided little evidence that associations of current activity with most metabolic traits differ
according to previous activity.
Change in physical activity and sedentary time (from age 12y–15y) in
relation to metabolic traits at age 15y
Increased total activity from age 12y–15y (per SD unit over mean 3.7y) was weakly associated
with most metabolic traits at age 15y in largely consistent directions as in previous analyses
(Figs 2 and 3; full results in S9 Table). Associations were most consistent across remnant,
VLDL-, and HDL-related traits (e.g., −3.51 × 10−12 mmol/l or −0.05 SD units; 95% CI = −0.10,
0.00; P = 0.05 for concentration of chylomicrons and XL VLDL particles with change in
CPM). Attenuations were slight with adjustment for FMI change.
Increased MVPA from age 12y–15y was weakly associated with metabolic traits at age 15y
(Figs 8 and 9; S10 Table). Effect sizes were small but directionally concordant with those seen
for current and longer-term MVPA measures in relation to cholesterol in VLDL and LDL
particles and triglycerides across all particle types, while SBP and DBP appeared to flip their
direction of effect. Cholesterol in HDL particles appeared most unassociated, in contrast to
previous MVPA measures (current and longer term). Increased sedentary time was largely
unassociated with cholesterol and triglycerides across all particle types, while stronger evidence
of association was observed for the amino acids phenylalanine (−0.001 mmol/l or −0.09 SD
units; 95% CI = −0.15, −0.03; P = 0.003) and tyrosine (−0.001 mmol/l or −0.06 SD units; 95%
CI = −0.12, 0.00; P = 0.05). These were unaltered by adjustment for MVPA or FMI (full results
in S11 Table).
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Supplementary results
Upon further adjustment for pre-baseline metabolic trait values measured at age 8y, attenua-
tions of associations of current (15y) total activity, MVPA, and sedentary time with most
metabolic traits at age 15y were minimal (all in S12 Table). For example, the pre-adjusted asso-
ciation estimate of higher total activity with lower triglycerides in VLDL particles at age 15y
(−0.03 mmol/l or −0.12 SD units; 95% CI = −0.18, −0.06; P = 1.06 × 10−4) was essentially
unchanged after adjusting for triglycerides in VLDL particles at age 8y (−0.11 SD units; 95%
Fig 6. Mutually adjusted associations of longer-term MVPA and sedentary time with blood pressure, cholesterol, and triglycerides at age 15y in
ALSPAC. Metabolic traits are in standardised units. Longer-term MVPA/sedentary time defined as mean of 3 measures (at age 12y, 14y, and 15y).
Models are adjusted for age, sex, ethnicity, maternal education, device wear time and wear month, alternative measure (MVPA or sedentary time) based
on mean across 3 measures, and fat mass index based on mean across 3 measures. ALSPAC, Avon Longitudinal Study of Parents and Children; MVPA,
moderate-to-vigorous physical activity.
https://doi.org/10.1371/journal.pmed.1002649.g006
Device-measured activity and metabolic traits
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002649 September 11, 2018 14 / 26
CI = −0.17, −0.04; P = 1.36 × 10−3). The same pattern was apparent for models of longer-term
total activity, MVPA, and sedentary time (S13 Table) and of change in these (S14 Table).
Associations of activity and sedentary time in relation to FMI at age 15y as an outcome are
shown in S15 Table. Higher current activity (at 15y) was associated with −0.39 kg/m2 (or −0.12
SD units of FMI; 95% CI = −0.17, −0.08; P = 2.96 × 10−7). Upon adjustment for a pre-baseline
measure of FMI at age 10y, this attenuated to −0.13 kg/m2 (or −0.04 SD units; 95% CI = −0.07,
−0.01; P = 0.01). A similar magnitude of association and attenuation was seen for MVPA.
Associations and their attenuations were more substantial with activity measures based on 3
occasions. For example, higher longer-term total activity was associated with −0.72 kg/m2 (or
−0.22 SD units of FMI; 95% CI = −0.28, −0.15; P = 3.32 × 10−10) at age 15y, and this attenuated
to −0.16 kg/m2 (or −0.05 SD units; 95% CI = −0.10, −0.01; P = 0.03) upon adjustment for FMI
Fig 7. Mutually adjusted associations of longer-term MVPA and sedentary time with lipoprotein particle diameter, apolipoproteins, fatty acids,
glycolysis factors, amino acids, ketones, and inflammatory factors at age 15y in ALSPAC. Metabolic traits are in standardised units. Longer-term
MVPA/sedentary time defined as mean of 3 measures (at age 12y, 14y, and 15y). Models are adjusted for age, sex, ethnicity, maternal education, device
wear time and wear month, alternative measure (MVPA or sedentary time) based on mean across 3 measures, and fat mass index based on mean across
3 measures. ALSPAC, Avon Longitudinal Study of Parents and Children; MVPA, moderate-to-vigorous physical activity.
https://doi.org/10.1371/journal.pmed.1002649.g007
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at 10y. Current and longer-term sedentary time were largely unassociated with FMI at age 15y
(likewise for change in activity and sedentary values).
The pattern and relative magnitude of associations of physical activity and sedentary time
with metabolic traits at age 15y were similar for each above analysis based on a complete case
sample of 755 participants (S2–S15 Tables).
Discussion
This study aimed to better describe associations of physical activity and sedentary time with
metabolic traits by integrating repeat accelerometry data taken several years apart with data
Fig 8. Mutually adjusted associations of change in MVPA and sedentary time with blood pressure, cholesterol, and triglycerides at age 15y in
ALSPAC. Metabolic traits are in standardised units. Change in MVPA/sedentary time defined as difference between measures at age 12y and 15y.
Models are adjusted for age, sex, ethnicity, maternal education, device wear time and wear month, alternative measure (MVPA or sedentary time), and
fat mass index based on change values. ALSPAC, Avon Longitudinal Study of Parents and Children; MVPA, moderate-to-vigorous physical activity.
https://doi.org/10.1371/journal.pmed.1002649.g008
Device-measured activity and metabolic traits
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002649 September 11, 2018 16 / 26
from targeted metabolomics. At age 15y, total activity was associated with a diverse set of meta-
bolic traits. Associations were strongest between higher-intensity activity and lower cholesterol
in VLDL lipoprotein particles, higher cholesterol in HDL particles, lower triglyceride in both
HDL and VLDL particles, and lower inflammatory glycoprotein acetyls, although association
magnitude was generally small. Associations appeared more robust for higher MVPA than
for lower sedentary time and were weak in relation to change in all activity types over several
years. Activity fluctuates over time, but associations of current activity with most metabolic
traits did not differ by previous activity. This suggests that the metabolic effects of physical
activity, if causal, depend on most recent engagement.
Fig 9. Mutually adjusted associations of change in MVPA and sedentary time with lipoprotein particle diameter, apolipoproteins, fatty acids,
glycolysis factors, amino acids, ketones, and inflammatory factors at age 15y in ALSPAC. Metabolic traits are in standardised units. Change in
MVPA/sedentary time defined as difference between measures at age 12y and 15y. Models are adjusted for age, sex, ethnicity, maternal education,
device wear time and wear month, alternative measure (MVPA or sedentary time), and fat mass index based on change values. ALSPAC, Avon
Longitudinal Study of Parents and Children; MVPA, moderate-to-vigorous physical activity.
https://doi.org/10.1371/journal.pmed.1002649.g009
Device-measured activity and metabolic traits
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002649 September 11, 2018 17 / 26
In this study, higher current activity based on one accelerometry occasion and higher lon-
ger-term activity based on the mean of three separate accelerometry occasions were similarly
associated with lower cholesterol in, and diameter of, VLDL particles; higher cholesterol in,
and diameter of, HDL particles; lower triglycerides in VLDL and HDL particles; and with
inflammatory traits, among others. Sedentary time was most associated with lower VLDL
lipid fractions, lower cholesterol in small HDL particles, and several amino acids; associa-
tions were not directionally consistent with cholesterol and triglycerides across VLDL and
LDL particles across sedentary time measures, however, suggesting these were less robust
and more prone to confounding. Confounders could be socioeconomic given that socioeco-
nomic advantage may lead children to accumulate a higher total sitting time from academic
activities like studying yet also to better overall health [36]. This could induce associations
between higher sitting time and favourable adiposity-driven lipid profiles. Differential mea-
surement error of MVPA and sedentary time by the waist-worn device could also help
explain unexpected directions of association, since light-intensity physical activities like
standing could be misclassified as sedentary time [37,38]. The magnitude of associations of
total activity and MVPA with metabolic traits were similar—as expected, given that CPM
describes intensity—and were in agreement with previous findings based on summary meta-
bolic traits among adolescents [5]. However, associations of change in activity over several
years were weak in relation to most metabolic traits; this was the case for both MVPA and
sedentary time.
To our knowledge, only one previous study used targeted NMR metabolomics to describe
associations of physical activity with metabolic traits [17]. That study pooled data from three
cohorts of adults each with two occasions of self-reported activity and observed similar associ-
ations of higher activity with lower cholesterol in VLDL and remnant lipoproteins, higher
cholesterol in HDL, lower triglycerides across all lipoproteins, and lower inflammatory glyco-
proteins, among others. Associations were generally stronger and effect sizes larger for most
traits (at about 0.5 SD units) compared with our study, and higher activity was more strongly
associated with lower cholesterol in LDL particles, whereas these were notably weak here.
Whether associations with LDL cholesterol were underestimated here due to smaller sample
size or were more realistically estimated due to enhanced activity measurement with accelero-
metry is unclear. Weaker associations here may also reflect a general lack of metabolic distur-
bances and a healthier overall metabolism given the younger age of participants examined
versus the previous study, in which mean age across cohorts was 31y–52y. This is also likely
to be the case given lower adiposity in the present study (mean BMI of 21.4 kg/m2) versus the
previous study (in which mean BMI was 24.6–27.1 kg/m2 across cohorts).
Physical activity is commonly thought to protect against cardiovascular disease [4], but
direct causal evidence from randomised controlled trials and other studies designed to
strengthen causal inference is sparse [39,40]. Higher cholesterol content in LDL and remnant
lipoproteins and higher total triglycerides are supported as causes of CHD through Mendelian
randomisation studies [41,42] and randomised controlled trials [43,44]. Lower HDL choles-
terol is not supported as a cause of CHD by the same standard of evidence [41,45]. In this
study, both physical activity and sedentary time were more strongly associated with the con-
centration, diameter, and cholesterol content of HDL particles than of LDL particles. Higher
activity was, however, also associated with cholesterol and triglyceride content in VLDL parti-
cles, a known LDL precursor. Together, this suggests that any protective effects of physical
activity for CHD risk via lipid pathways likely operate through triglycerides and remnant
cholesterol content, not LDL cholesterol itself. Higher activity was also associated with lower
glycoprotein acetyls, which are inflammatory acute-phase reactants associated with future
cardiovascular events [46] and closely related to atherosclerotic inflammatory interleukins
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[47,48]. Associations with inflammatory markers were more reliably driven by higher MVPA
than lower sedentary time duration.
Our results also suggest that associations of current activity with most metabolic traits do
not differ depending upon previous levels of activity. Blood pressure appeared to be an excep-
tion, with notably larger effect sizes based on multi-occasion assessments of activity, but statis-
tical evidence for interaction was weak. Dependency of current activity on previous activity for
metabolic trait associations have not been previously examined using device-measured activity,
but numerous studies conducted on college alumni using historical activity from self-reported
recall found little to no additional benefit of high previous activity (e.g., having been a college
athlete) above current activity levels in relation to reduced LDL cholesterol, triglycerides [49],
and coronary heart disease risk [50–52]. Mechanistically, the lipolytic and anti-inflammatory
effects of physical activity are initiated through skeletal muscle contraction [53], and when con-
traction ceases to be frequent among previously active adults, these benefits are known to dete-
riorate in a matter of days, even to levels experienced among sedentary adults [54]. Together,
this suggests that the cardiometabolic benefits of physical activity are likely to be acute rather
than cumulative in nature, with meaningful reductions in disease risk requiring sustained
activity. The same may apply to more structural changes to vasculature, which appear to
improve cumulatively with continued activity but deteriorate when activity ceases [55].
Associations of activity with metabolic traits showed only modest attenuation with adjust-
ment for objective total fat mass suggesting that confounding by adiposity does not fully
explain results. Attenuations were also slight upon adjustment for these same metabolic traits
measured pre-baseline in a supplementary analysis at age 8y, suggesting that reverse causation
is also unlikely. Adiposity was notably low among participants, however—with a mean BMI
of 21.4 kg/m2 and only 4.2% with obesity—which would have reduced an influence of adipos-
ity on activity levels. Results may also be susceptible to residual confounding by aspects of
adiposity not captured by a total DXA measure. Effect sizes were also small before these adjust-
ments. Meta-analyses of observational studies indicate that obesity versus normal weight more
greatly amplifies risk of type 2 diabetes than does inactivity versus high activity (a 6-fold versus
1.2-fold increase) [56]. Presently, in supplementary analyses, higher current and longer-term
activity were also associated with lower DXA adiposity as an outcome at age 15y. These effect
sizes were of a similarly small magnitude as the most strongly associated metabolic traits, but
attenuations were more substantial upon adjustment for pre-baseline adiposity at age 10y,
attenuating over 4-fold in the case of longer-term total activity. This suggests that much of the
association of higher activity with lower subsequent adiposity is driven by reverse causation in
this data. In line with this, a recent genome-wide association study for accelerometry physical
activity in the UK Biobank cohort identified a small set of common genetic variants robustly
associated with total activity, and Mendelian randomisation analyses with these variants sug-
gested a lowering effect of total activity on fat mass and blood pressure [23]. The standardised
effect size was 6 times larger in the reverse direction, however—from fat mass to inactivity—
suggesting that adiposity affects activity levels more than activity levels affect adiposity. Effect
sizes matter a great deal for public health messaging since the existence of an association, or
indeed a causal effect, does not alone describe its importance. Future work should compare
magnitudes of effect size between common risk factors as the rate of discovery and the need to
prioritise limited public health resources both increase.
Strengths and limitations
Main strengths of this study include its use of three repeat accelerometry measures of physical
activity and sedentary time taken several years apart, which allowed examination of longer-
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term activity, interaction by previous activity, and change in activity; its use of detailed meta-
bolic trait data from targeted metabolomics; and its use of DXA measures for adiposity
adjustment. Several clinical traits (SBP, DBP, insulin, and C-reactive protein) were included
alongside metabolomics-derived traits, which allowed comparison of association strength
between established and novel traits. The metabolic traits examined, like all biological charac-
teristics, are subject to within-person variability over time. The expected degree of short- and
long-term stability of NMR-derived traits has not been formally estimated (e.g., via intraclass
correlation coefficients), but metabolic trait concentrations quantified through NMR are
known to be highly consistent with those quantified through routine clinical chemistry assays
and more-specialised methods including gas chromatography (correlations commonly >0.9)
[57–59]. Blood was drawn while fasting at a largely consistent time of day, limiting potential
for diurnal effects on traits like inflammatory markers [60]. Participants were of a young age,
which reduced potential for confounding in analyses by subclinical chronic diseases and health
behaviours like smoking, which were uncommon. Young participant age may, however, limit
generalisability of associations to older age groups given that self-reported activity levels tend
to peak in childhood, decline at adolescence, and decline further past the age of 50y [61]. Also
notable is that observations spanned puberty, which is a substantial period of growth and
maturity with implications for metabolism [62,63]. Specifically, a faster rate of pubertal growth
as often indicated through earlier age at menarche among females and voice breaking among
males is associated with numerous metabolic traits [63] and with a higher risk of developing
type 2 diabetes and coronary heart disease in adulthood [64,65]. These associations may be
largely confounded by pre-pubertal adiposity, however, given that higher adiposity in child-
hood induces earlier puberty [66] and tracks into later life stages [67,68] and that substantial
overlap exists between genetic variants associated with puberty timing and adiposity [69].
Adjusting for BMI measured before puberty onset in observational studies has substantially
attenuated associations of puberty timing with postpubertal adiposity and metabolic traits
[70,71]. Adjustment for objectively measured adiposity over the pubertal period, as done here,
likely accounts for much of the influence of pubertal growth on subsequent metabolic trait lev-
els while avoiding the need to additionally consider this often imprecisely measured exposure.
The duration of accelerometry measurement on each occasion was relatively short (3–7 d),
and although repeat measures were used, the length of time between the first and last accelero-
metry measure was also relatively short, at about 3.7y. Longer time durations within and
between activity assessments would make us better able to distinguish biological patterns from
chance variation, especially in analyses of interaction and change. A simple mean of three mea-
surement occasions was used to estimate longer-term activity and sedentary time across these
time periods, which does not describe different trajectories of activity; the short time span
between measures and the large scale of outcome data limits such approaches. Activity was
recorded using uniaxial accelerometers, which predated more sensitive triaxial devices; future
studies could expand upon metabolic trait associations using repeated measures of triaxial
devices with longer durations.
Conclusions
Our results support associations of physical activity with metabolic traits that are small in
magnitude and more robust for higher MVPA than lower sedentary time. Activity was most
strongly associated with cholesterol content in VLDL and HDL lipoprotein particles, with tri-
glyceride content in all particle types, and with inflammatory glycoprotein acetyls. Associa-
tions were weaker in relation to change in activity over several years—likewise for MVPA and
sedentary time. Activity fluctuates over time, but associations of current activity with most
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metabolic traits did not differ by previous activity. This suggests that the metabolic effects of
physical activity, if causal, depend on most recent engagement.
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